Medicare clears Dana-Farber Cancer Institute
The Centers for Medicare and Medicaid Services will not terminate Dana-Farber Cancer Institute from the Medicare program, according to a June 12 letter obtained by Axios. We reported in March that the federal agency threatened to cut off Medicare funding for the Boston-based cancer hospital after discovering Dana-Farber inappropriately relied on the adjacent Brigham and Women's Hospital to handle many day-to-day functions.
Officials with the Massachusetts Department of Public Health visited Dana-Farber last week, on behalf of CMS, and determined the hospital was back in compliance with Medicare's rules. The CMS rarely revokes Medicare funding, but will threaten to do so if it believes there are egregious violations. Dana-Farber's "plan of correction" can be read here.